GLS2 and cancer: The phosphorylation activation of Stat1 Ser727, rather than Tyr701, promotes ferroptosis through transcriptional inhibition of Nrf2 expression and highlights MgIG and GA as potential therapeutic approaches to enhance the safety of Crizotinib- based cancer therapy.